ROSES-S: Statement from the World Health Organization on the reporting of seroepidemiologic studies for SARS-CoV-2

World Health Organization Seroepidemiology Technical Working Group

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)

Abstract

Well-designed population-based seroepidemiologic studies can be used to refine estimates of infection severity and transmission, and are therefore an important component of epidemic surveillance. However, the interpretation of the results of seroepidemiologic studies for SARS-CoV-2 has been hampered to date principally by heterogeneity in the quality of the reporting of the results of the study and a lack of standardized methods and reporting. We provide here the ROSES-S: Reporting of Seroepidemiologic studies—SARS-CoV-2. This is an updated checklist of 22 items that should be included in the reporting of all SARS-CoV-2 seroepidemiologic studies, irrespective of study design.

Original languageEnglish
Pages (from-to)561-568
Number of pages8
JournalInfluenza and other Respiratory Viruses
Volume15
Issue number5
DOIs
Publication statusPublished - Sep 2021

Bibliographical note

Funding Information:
The authors have not declared a specific grant for this research from any funding agency in the public, commercial, or not-for-profit sectors

Publisher Copyright:
© 2021 The Authors. Influenza and Other Respiratory Viruses Published by John Wiley & Sons Ltd.

Keywords

  • SARS-CoV-2
  • emerging
  • infectious diseases
  • seroepidemiologic Studies

Fingerprint

Dive into the research topics of 'ROSES-S: Statement from the World Health Organization on the reporting of seroepidemiologic studies for SARS-CoV-2'. Together they form a unique fingerprint.

Cite this